New Delhi [India], September 25 (ANI): The Municipal Corporation of Delhi (MCD) has demolished 543 properties, sealed 178 others and issued 354 show-cause notices for unauthorised construction in the 17-day period following…
New Delhi [India], September 25 (ANI): Bharatiya Janata Party (BJP) National President Nitin Nabin is scheduled to undertake a two-day visit to West Bengal on September 27 and 28 as part of…
Bhopal (Madhya Pradesh) [India], September 25 (ANI): Madhya Pradesh Chief Minister Mohan Yadav and Union Minister for Road Transport and Highways Nitin Gadkari on Friday launched Mukhyamantri Sugam Parivahan Seva and PM…
New Delhi [India], September 25 (ANI): India’s hiring momentum is expected to strengthen in the second half of FY27, driven by workforce expansion in e-commerce and technology startups, travel and hospitality, retail,…
New Delhi [India], September 25 (ANI): India’s hiring momentum is expected to strengthen in the second half of FY27, driven by workforce expansion in e-commerce and technology startups, travel and hospitality, retail,…
New Delhi [India], September 25 (ANI): While global tourism has strengthened across most countries, rising visitor numbers are not translating into wider economic and social benefits, according to a World Economic Forum…
PNNNew Delhi [India], September 25: In 2026, a new generation of entrepreneurs, professionals, innovators, and organisations is making its presence felt across sectors including technology, AI, digital marketing, law, tourism, wellness, entertainment,…
PNNNew Delhi [India], September 25: In 2026, a new generation of entrepreneurs, professionals, innovators, and organisations is making its presence felt across sectors including technology, AI, digital marketing, law, tourism, wellness, entertainment,…
VMPLSan Francisco [US], September 25: The U.S. Food and Drug Administration has approved the SELUTION SLR™ (Sustained Limus Release) Drug-Eluting Balloon for coronary in-stent restenosis (ISR), Cordis announced this month – making…
VMPLSan Francisco [US], September 25: The U.S. Food and Drug Administration has approved the SELUTION SLR™ (Sustained Limus Release) Drug-Eluting Balloon for coronary in-stent restenosis (ISR), Cordis announced this month – making…
